tirzepatide 2.5 Lilly launches lower-price weight-loss drug Zepbound without injector pen Mounjaro Tirzepatide 2.5/5 mg Injection

No evidence of severe endocrine, hepatic, or cardiovascular adverse effects has been observed in available preclinical data

Semaglutide has transformed diabetes management through a series of groundbreaking clinical trials that demonstrated its efficacy

Survodutide (Boehringer Ingelheim/Zealand) is a GLP-1/glucagon dual agonist showing about 19% in Phase 2 and now in Phase 3

Jencycla works by suppressing ovulation in about 50% of users, and thickening the cervical mucus in order to make it more difficult for sperm to penetrate and a fertilized egg to implant

This dual-purpose prescribing enables patients to receive insurance coverage for the on-label indication

Think back to the last time you went on a diet